What is the main business of Spółdzielnia Chemiczno - Farmaceutyczna Spółdzielnia Pracy Espefa?

The main business activity of the cooperative focuses on manufacture of pharmaceutical preparations.

When was the cooperative founded?

The cooperative was registered in the Polish National Court Register (KRS) on January 16, 2002.

Where is the headquarters located?

The headquarters is located at: Juliusza Lea 208, 30-133 Kraków.

What period do the latest financial data cover?

The latest available financial statement covers the period from January 1, 2025 to December 31, 2025.

How much revenue was generated?

In 2025, the cooperative generated total revenue of USD 6,510,563, representing an increase of 12.9% compared to 2024.

Is the cooperative profitable?

Yes, the cooperative recorded a net profit of USD 105,004 in 2025, meaning the cooperative increased its profit by 19.6%.

What is the largest operating cost?

The largest operating cost category falls under cost of goods and materials sold. This category amounted to USD 1,753,692 in 2025, representing 28% of all operating expenses.

Chemiczno - Farmaceutyczna Spółdzielnia Pracy EspefaCooperative

Manufacture of pharmaceutical preparations

KRS: NIP: REGON:

Overview

Status

Active

Registry date

2002-01-16

Registered address

Juliusza Lea 208, 30-133 Kraków, Poland

Electronic delivery address

AE:PL-48240-35246-SRAFS-15

Financials

Revenue history (in k)

Filing timeliness

2 of 6 financial statements were filed late (the longest delay 104 days for 2025). 5 of 6 audited by a statutory auditor.

202527/10/2026
202409/06/2025
202324/06/2024
202229/05/2023
202120/05/2022
202029/10/2021

Filed on timeDelayFiling deadline

Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.

Statistics

How the company ranks by revenue within its industry, region and across Poland in 2025.

Results vs industry

Revenue

This companyUSD 6.51mMedianUSD 917.74kAverageUSD 25.73m

Net profit

This companyUSD 105.00kMedianUSD 14.44kAverageUSD 2.75m

Operating costs

This companyUSD 6.25mMedianUSD 860.03kAverageUSD 21.34m

Assets

This companyUSD 6.32mMedianUSD 883.09kAverageUSD 31.39m

Industry

Trademarks

Chemiczno - Farmaceutyczna Spółdzielnia Pracy Espefa holds 8 active trademarks registered with the Polish Patent Office. 36 marks have expired or were not registered. The first mark was filed in 1994.

Mark	Number	Classes	Status	Protected until
ESPEVIT(word)	Z.546515	5	Protected	Aug 25, 2032
Espinosine forte(word)	Z.538160	5	Protected	Dec 24, 2031
Espinosine(word)	Z.538158	5	Protected	Dec 24, 2031
ASCOFER(word)	Z.512894	5	Protected	Apr 27, 2030
ESPEFA	Z.467207	5	Protected	Feb 7, 2037

Mark	Protected until
ESPEVIT(word)	Aug 25, 2032
Espinosine forte(word)	Dec 24, 2031
Espinosine(word)	Dec 24, 2031
ASCOFER(word)	Apr 27, 2030
ESPEFA	Feb 7, 2037

Authorized Representatives

Aleksandra Mróz Lubińska – President of the Management Board

Anna Matyja – Management Board Member

Renata Znachowska – Zastępca Prezesa Zarządu

Manner of representation

Two members of the management board jointly, or one member of the management board together with an attorney-in-fact.

Supervisory board

Anna Adamczyk – Supervisory Board Member

Anna Janas – Supervisory Board Member

Krzysztof Cerkaski – Supervisory Board Member

Małgorzata Górni – Supervisory Board Member

Katarzyna Kasprzak – Supervisory Board Member

Beneficial owners

Person	Rights

Bank accounts

Registered as a VAT taxpayer on 1997-01-01.

Bank Pekao SA
32 1240 4533 1787 0011 0304 9671
Bank Pekao SA
67 1240 2294 1111 0000 3709 1846
Bank Pekao SA
21 1240 2294 1111 0011 3216 8936

Debt

No entries in the National Debtors Register (KRZ).

Real estate

Type	Amount
Land (incl. perpetual usufruct)	$1.3M$1,270,221
Buildings and premises	$1.1M$1,064,004

Public aid

21 public aid cases recorded, with a total value of $1,256,025.

Grant date	Purpose	Gross amount	Granting body
Dec 2, 2024	Aid for research and development projects: industrial research	––	Prezes Polskiej Agencji Rozwoju Przedsiębiorczości
Dec 2, 2024	Aid for research and development projects: experimental development	––	Prezes Polskiej Agencji Rozwoju Przedsiębiorczości
Apr 15, 2024	De minimis aid (in accordance with Commission Regulation No 1407/2013 or earlier)	––	Małopolska Agencja Rozwoju Regionalnego S.A.

European Funds

4 projects co-financed from European Funds recorded, with total EU co-financing of $914,976.

Start	Project	EU co-financing	Programme
2025-01-01	Development of an innovative drug containing methocarbamol	$308.2K$308,193	European Funds for a Modern Economy
2020-07-01	Working capital grant for Chemiczno - Farmaceutyczna Spółdzielnia Pracy ESPEFA	$72,261$72,261	Operational Programme Smart Growth
2019-06-01	Implementation of an R&D project by Espefa to develop and launch a new medicine in sachets	$352.2K$352,205	Regional Operational Programme for the Małopolskie Voivodeship for 2014-2020

Regulatory authorisations

Authority	Type	Status
BDO	Waste generation	Active

Competitors

	Name	Revenue	Website
	Farmaceutyczna Spółdzielnia Pracy GalenaCooperative	$14,048,375.71	galena.pl

FAQ

Last updated: 2026-10-27